CALCIUM IS ESSENTIAL IN NORMALIZING INTOLERANCE TO GLUCOSE THAT ACCOMPANIES VITAMIN-D DEPLETION INVIVO

被引:73
作者
BEAULIEU, C
KESTEKIAN, R
HAVRANKOVA, J
GASCONBARRE, M
机构
[1] HOP ST LUC,CTR RECH CLIN ANDRE VIALLET,264 RENE LEVESQUE BLVD EST,MONTREAL H2X 1P1,QUEBEC,CANADA
[2] UNIV MONTREAL,DEPT PHARMACOL & MED,MONTREAL H3C 3J7,QUEBEC,CANADA
关键词
D O I
10.2337/diabetes.42.1.35
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
Vitamin D is essential for normal insulin secretion in vivo and in vitro. The differential effect of calcium and of the vitamin D endocrine system in the insulin response to secretagogues is still a subject of debate. To study the roles of calcium and the vitamin D system in the in vivo insulin response, GTT and insulin sensitivity tests were conducted in rats presenting vitamin D depletion and hypocalcemia or vitamin D depletion supplemented with calcium alone for 3, 7, or 14 days, vitamin D3 (6.5 mumol/day x 7 days), or 1,25(OH)2D3 (28 pmol(day x 7 days). Serum calcium was 1.28 +/- 0.04 mM in hypocalcemic vitamin D-depleted rats, 1.47 +/- 0.06 (NS), 1.8 +/- 0.2 (P < 0.0002), and 2.04 +/- 0.07 (P < 0.0001) mM after 3, 7, or 14 days, respectively, of calcium supplementation; vitamin Dt- or 1,25(OH)2D3-supplemented animals had serum calcium of 2.61 +/- 0.04 or 2.48 +/- 0.05 mM (P < 0.0001 vs. hypocalcemic vitamin D-depleted rats). Rats with hypocalcemia and vitamin D depletion had significantly higher glucose concentrations (P < 0.0005) and lower insulin response during GTT than all other groups (P < 0.001). Differences in insulin sensitivity could not account for differences in response because exogenous insulin administration led to a similar drop in glucose concentrations in all groups, with the nadir averaging 51.7 +/- 2.6% of initial values. To distinguish between calcium and the vitamin D system in the GTT response, rats were treated with a nonhypercalcemic analogue of 1,25(OH)2D3, OCT (28 pmol/day x 4-7 days) with or without dietary calcium. Serum calcium Was 1.23 +/- 0.04 vs. 2.09 +/- 0.02 mM in the absence or presence of dietary calcium (P < 0.0001), but normalization of GTT only happened in the presence of calcium. A time course of the calcium effect in vitamin D-depleted rats indicated that 7 days of high dietary calcium intake was needed to normalize GTT, with a significant correlation coefficient being observed between serum calcium and the maximum insulin response (r = 0.5172, P < 0.004). Our data indicate that vitamin D depletion with hypocalcemia is associated with normal insulin sensitivity but glucose intolerance caused by inadequate insulin secretion in response to glucose. Calcium alone contributes in normalizing GTT, whereas the 1,25(OH)2D3 analogue OCT is unable to normalize GTT at a dose equimolar to that of 1,25(OH)2D, in the absence of calcium, suggesting that hypocalcemia predominates over vitamin D depletion in the glucose intolerance of vitamin D deficiency.
引用
收藏
页码:35 / 43
页数:9
相关论文
共 62 条
[1]  
ABE J, 1986, CANCER RES, V46, P6316
[2]  
ABE J, 1991, VITAMIN D, P449
[3]   RADIOIMMUNOASSAY STUDIES OF INTESTINAL CALCIUM-BINDING PROTEIN IN PIG .2. DISTRIBUTION OF INTESTINAL CABP IN PIG TISSUES [J].
ARNOLD, BM ;
KUTTNER, M ;
WILLIS, DM ;
HITCHMAN, AJW ;
HARRISON, JE ;
MURRAY, TM .
CANADIAN JOURNAL OF PHYSIOLOGY AND PHARMACOLOGY, 1975, 53 (06) :1135-1140
[4]   LYSOPHOSPHATIDYLINOSITOL - A POTENTIAL MEDIATOR OF 1,25-DIHYDROXYVITAMIN-D-INDUCED INCREMENTS IN HEPATOCYTE CYTOSOLIC CALCIUM [J].
BARAN, DT ;
KELLY, AM .
ENDOCRINOLOGY, 1988, 122 (03) :930-934
[5]   1,25 DIHYDROXYVITAMIN-D INCREASES HEPATOCYTE CYTOSOLIC CALCIUM LEVELS - A POTENTIAL REGULATOR OF VITAMIN-D-25-HYDROXYLASE [J].
BARAN, DT ;
MILNE, ML .
JOURNAL OF CLINICAL INVESTIGATION, 1986, 77 (05) :1622-1626
[6]  
BARAN DT, 1991, J BONE MINER RES, V6, P1269
[7]   INDUCTION OF MONOCYTIC DIFFERENTIATION AND BONE-RESORPTION BY 1,25-DIHYDROXYVITAMIN-D3 [J].
BARSHAVIT, Z ;
TEITELBAUM, SL ;
REITSMA, P ;
HALL, A ;
PEGG, LE ;
TRIAL, J ;
KAHN, AJ .
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA-BIOLOGICAL SCIENCES, 1983, 80 (19) :5907-5911
[9]  
BILLAUDEL BJL, 1990, AM J PHYSL ENDOCRINO, V259, pE643
[10]  
BLEICHER SJ, 1976, HORMONES HUMAN BLOOD, P165